Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;28:738-742

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knoblich, P. R.
Right arrow Articles by Villarreal, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knoblich, P. R.
Right arrow Articles by Villarreal, D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure

(Hypertension. 1996;28:738-742.)
© 1996 American Heart Association, Inc.


Articles

Pressure-Dependent Renin Release During Chronic Blockade of Nitric Oxide Synthase

Penny R. Knoblich; Ronald H. Freeman; Daniel Villarreal

Department of Physiology, University of Missouri School of Medicine, Columbia.

Correspondence to Ronald H. Freeman, Department of Physiology, Medical Science Building, MA415, University of Missouri School of Medicine, Columbia, MO 65212.

We evaluated pressure-dependent stimulation of renin release in rats with sustained hypertension induced by chronic blockade of nitric oxide synthase with N{omega}-nitro-L-arginine methyl ester (L-NAME) for 5 to 7 days. Rats were anesthetized and catheters were inserted into the carotid artery and abdominal aorta for measurement of arterial pressures. An adjustable snare was placed around the suprarenal aorta, and this snare was tightened to reduce renal perfusion pressure. Pressure-dependent renin release was evaluated in hypertensive rats by reducing renal perfusion pressure to 125, 85, and 65 mm Hg. Renin release was also evaluated in normotensive control rats at these same pressures. Basal systemic arterial pressures averaged 159±3 and 124±4 mm Hg (P<.001), respectively, in the L-NAME–treated (n=22) and normotensive control (n=18) rats. Basal plasma renin activity was lower in L-NAME than control rats (5.0±0.3 versus 9.5±1.3 U, P<.01), and plasma renin activity was markedly attenuated at all comparable levels of renal perfusion pressure. Maximal plasma renin activity levels were achieved at perfusion pressures reduced to 65 mm Hg, and plasma renin activity averaged 14±2 and 34±7 U (P<.01) in L-NAME hypertensive and control rats, respectively. However, infusion of the nitric oxide donor sodium nitroprusside similarly stimulated plasma renin activity levels to 39±3 and 45±3 U (P>.05), in the hypertensive and normal control groups, respectively. Overall, these findings are consistent with the hypothesis that prolonged L-NAME administration attenuates pressure-dependent renin release by inhibiting nitric oxide formation, which may function as a paracrine mechanism inversely linking renal perfusion pressure with the stimulation of renin release.


Key Words: perfusion • renin • nitric oxide • nitroprusside




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. M. Siragy, T. Inagami, and R. M. Carey
NO and cGMP mediate angiotensin AT2 receptor-induced renal renin inhibition in young rats
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1461 - R1467.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Schweda, F. Segerer, H. Castrop, J. Schnermann, and A. Kurtz
Blood Pressure-Dependent Inhibition of Renin Secretion Requires A1 Adenosine Receptors
Hypertension, October 1, 2005; 46(4): 780 - 786.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Ichihara, H. Suzuki, Y. Miyashita, M. Naitoh, M. Hayashi, and T. Saruta
Transmural pressure inhibits prorenin processing in juxtaglomerular cell
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1999; 277(1): R220 - R228.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Kurtz and C. Wagner
Role of nitric oxide in the control of renin secretion
Am J Physiol Renal Physiol, December 1, 1998; 275(6): F849 - F862.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Zatz and C. Baylis
Chronic Nitric Oxide Inhibition Model Six Years On
Hypertension, December 1, 1998; 32(6): 958 - 964.
[Full Text] [PDF]


Home page
StrokeHome page
P. Moreau, H. Takase, L. V. d'Uscio, T. F. Luscher, and G. L. Baumbach
Effect of Chronic Nitric Oxide Deficiency on Angiotensin II–Induced Hypertrophy of Rat Basilar Artery • Editorial Comment
Stroke, May 1, 1998; 29(5): 1031 - 1036.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Kurtz, K.-H. Gotz, M. Hamann, and C. Wagner
Stimulation of renin secretion by nitric oxide is mediated by phosphodiesterase 3
PNAS, April 14, 1998; 95(8): 4743 - 4747.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Kurtz, K.-H. Gotz, M. Hamann, M. Kieninger, and C. Wagner
Stimulation of renin secretion by NO donors is related to the cAMP pathway
Am J Physiol Renal Physiol, April 1, 1998; 274(4): F709 - F717.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. H. Beierwaltes, D'A. L. Potter, and E. G. Shesely
Renal baroreceptor-stimulated renin in the eNOS knockout mouse
Am J Physiol Renal Physiol, January 1, 2002; 282(1): F59 - F64.
[Abstract] [Full Text] [PDF]